ENDRA Life Sciences Inc.
NDRA
$4.84
-$0.44-8.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.06M | 3.23M | 4.75M | 6.40M | 1.13M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 115.30K | 204.20K | 217.10K | 312.70K | 135.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.18M | 3.43M | 4.96M | 6.71M | 1.27M |
|
|
|||||
| Total Current Assets | 2.18M | 3.43M | 4.96M | 6.71M | 1.27M |
| Net Property, Plant & Equipment | 619.00K | 647.30K | 310.10K | 364.10K | 425.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 371.40K | 371.40K | 3.11M | 3.37M | 3.37M |
| Total Assets | 3.17M | 4.45M | 8.38M | 10.44M | 5.06M |
|
|
|||||
| Total Accounts Payable | 223.60K | 269.70K | 279.40K | 300.40K | 521.60K |
| Total Accrued Expenses | 216.10K | 68.90K | 139.10K | 599.10K | 425.90K |
| Short-term Debt | -- | 169.70K | 208.20K | 268.00K | 91.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 126.10K | 96.90K | 187.30K | 182.70K | 178.20K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 565.80K | 605.20K | 814.00K | 1.35M | 1.22M |
|
|
|||||
| Total Current Liabilities | 565.80K | 605.20K | 814.00K | 1.35M | 1.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 169.70K | 208.20K | 268.00K | 91.00K |
| Capital Leases | 461.20K | 487.50K | 49.80K | 98.40K | 145.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 390.70K | 799.30K | 910.60K | -- | -- |
| Total Liabilities | 1.42M | 1.89M | 1.77M | 1.45M | 1.36M |
|
|
|||||
| Common Stock & APIC | 106.23M | 106.00M | 105.89M | 105.93M | 98.40M |
| Retained Earnings | -104.47M | -103.44M | -99.29M | -96.94M | -94.71M |
| Treasury Stock & Other | -- | -- | -- | 0.00 | 300.00 |
| Total Common Equity | 1.75M | 2.56M | 6.60M | 8.99M | 3.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.75M | 2.56M | 6.60M | 8.99M | 3.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.75M | 2.56M | 6.60M | 8.99M | 3.70M |
|
|
|||||